Back to Search
THOMAS MALAN, MD, PHD
MD, PHD
Anesthesiology Physician
NPI: 1487752846IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
18547(AZ)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1985
Research & Publications (20)
The cyclooxygenase-2-specific inhibitor parecoxib sodium is as effective as 12 mg of morphine administered intramuscularly for treating pain after gynecologic laparotomy surgery.
PMID 15673875·Anesth Analg·2005
3-trial
Lipid mediators regulating pain sensitivity.
PMID 16099397·Prostaglandins Other Lipid Mediat·2005
6-review
Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.
PMID 12657858·Anesthesiology·2003
3-trial
CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?
PMID 12550743·Curr Opin Pharmacol·2003
6-review
Inhibition of pain responses by activation of CB(2) cannabinoid receptors.
PMID 12505700·Chem Phys Lipids·2002
6-review
Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain.
PMID 11981157·Anesthesiology·2002
7-preclinical
Severe, refractory hypotension during anesthesia in a patient on chronic clomipramine therapy.
PMID 11465569·Anesthesiology·2001
5-case
Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats.
PMID 10779675·Pain·2000
7-preclinical
Spinal NK-1 receptor-expressing neurons and descending pathways support fentanyl-induced pain hypersensitivity in a rat model of postoperative pain.
PMID 19200067·Eur J Neurosci·2009
7-preclinical
Constitutive activity at the cannabinoid CB1 receptor is required for behavioral response to noxious chemical stimulation of TRPV1: antinociceptive actions of CB1 inverse agonists.
PMID 18987195·J Neurosci·2008
7-preclinical
Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity.
PMID 18038967·J Med Chem·2007
7-preclinical
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
PMID 15705714·Proc Natl Acad Sci U S A·2005
7-preclinical
Differential blockade of nerve injury-induced thermal and tactile hypersensitivity by systemically administered brain-penetrating and peripherally restricted local anesthetics.
PMID 15219260·J Pain·2004
4-observational
Production of paradoxical sensory hypersensitivity by alpha 2-adrenoreceptor agonists.
PMID 15166576·Anesthesiology·2004
4-observational
Mouse strains that lack spinal dynorphin upregulation after peripheral nerve injury do not develop neuropathic pain.
PMID 14667440·Neuroscience·2004
4-observational
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS.
PMID 12917492·Proc Natl Acad Sci U S A·2003
7-preclinical
Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors.
PMID 14508331·Anesthesiology·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1501 N CAMPBELL AVE
TUCSON, AZ 85724 - Phone
- (520) 694-8888
Quick Facts
- NPI
- 1487752846
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile